The Proapoptotic Function of Noxa in Human Leukemia Cells Is Regulated by the Kinase Cdk5 and by Glucose

Molecular Cell

Volumn 40, Issue 5, 2010, Pages 823-833

  Lowman, Xazmin H ^a,b   McDonnell, Maureen A ^a   Kosloske, Ashley ^c   Odumade, Oludare A ^a,c   Jenness, Christopher ^d   Karim, Christine B ^c   Jemmerson, Ronald ^a,b,c   Kelekar, Ameeta ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d LINFIELD COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLUCOSE; PENTOSE PHOSPHATE; PROTEIN NOXA; SERINE;

APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; GLUCOSE INTAKE; GLYCOLYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TURNOVER TIME;

APOPTOSIS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE 5; GLUCOSE; HUMANS; LEUKEMIA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 78649973189     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2010.11.035     Document Type: Article

References (42)

1. Abedin M.J., Wang D., McDonnell M.A., Lehmann U., Kelekar A. Autophagy delays apoptotic death in breast cancer cells following DNA damage. Cell Death Differ. 2007, 14:500-510.
2. Alves N.L., Derks I.A., Berk E., Spijker R., van Lier R.A., Eldering E. The Noxa/Mcl-1 axis regulates susceptibility to apoptosis under glucose limitation in dividing T cells. Immunity 2006, 24:703-716.
3. Alves N.L., van Lier R.A., Eldering E. Withdrawal symptoms on display: Bcl-2 members under investigation. Trends Immunol. 2007, 28:26-32.
4. Ashcroft S.J., Weerasinghe L.C., Bassett J.M., Randle P.J. The pentose cycle and insulin release in mouse pancreatic islets. Biochem. J. 1972, 126:525-532.
5. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 1999, 294:1351-1362.
6. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., Huang D.C. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 2005, 17:393-403.
7. Czabotar P.E., Lee E.F., van Delft M.F., Day C.L., Smith B.J., Huang D.C., Fairlie W.D., Hinds M.G., Colman P.M. Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc. Natl. Acad. Sci. USA 2007, 104:6217-6222.
8. Danial N.N., Walensky L.D., Zhang C.Y., Choi C.S., Fisher J.K., Molina A.J., Datta S.R., Pitter K.L., Bird G.H., Wikstrom J.D., et al. Dual role of proapoptotic BAD in insulin secretion and beta cell survival. Nat. Med. 2008, 14:144-153.
9. Datta S.R., Katsov A., Hu L., Petros A., Fesik S.W., Yaffe M.B., Greenberg M.E. 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 2000, 6:41-51.
10. Dhavan R., Tsai L.H. A decade of CDK5. Nat. Rev. Mol. Cell Biol. 2001, 2:749-759.
11. Erster S., Mihara M., Kim R.H., Petrenko O., Moll U.M. In vivo mitochondrial p53 translocation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation. Mol. Cell. Biol. 2004, 24:6728-6741.
12. Goodyear S., Sharma M.C. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5. Exp. Mol. Pathol. 2007, 82:25-32.
13. Hallaert D.Y., Spijker R., Jak M., Derks I.A., Alves N.L., Wensveen F.M., de Boer J.P., de Jong D., Green S.R., van Oers M.H., Eldering E. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection. Cell Death Differ. 2007, 14:1958-1967.
14. Hershko T., Ginsberg D. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J. Biol. Chem. 2004, 279:8627-8634.
15. Hijikata M., Kato N., Sato T., Kagami Y., Shimotohno K. Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J. Virol. 1990, 64:4632-4639.
16. Kim J.Y., Ahn H.J., Ryu J.H., Suk K., Park J.H. BH3-only protein Noxa is a mediator of hypoxic cell death induced by hypoxia-inducible factor 1alpha. J. Exp. Med. 2004, 199:113-124.
17. Lalioti V., Muruais G., Dinarina A., van Damme J., Vandekerckhove J., Sandoval I.V. The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes. Proc. Natl. Acad. Sci. USA 2009, 106:4249-4253.
18. Liang Y., Buettger C., Berner D.K., Matschinsky F.M. Chronic effect of fatty acids on insulin release is not through the alteration of glucose metabolism in a pancreatic beta-cell line (beta HC9). Diabetologia 1997, 40:1018-1027.
19. Luo S., Vacher C., Davies J.E., Rubinsztein D.C. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J. Cell Biol. 2005, 169:647-656.
20. Maher J.C., Wangpaichitr M., Savaraj N., Kurtoglu M., Lampidis T.J. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose. Mol. Cancer Ther. 2007, 6:732-741.
21. Mapelli M., Massimiliano L., Crovace C., Seeliger M.A., Tsai L.H., Meijer L., Musacchio A. Mechanism of CDK5/p25 binding by CDK inhibitors. J. Med. Chem. 2005, 48:671-679.
22. Maurer U., Charvet C., Wagman A.S., Dejardin E., Green D.R. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol. Cell 2006, 21:749-760.
23. Medina M.A., Nunez de Castro I. Glutaminolysis and glycolysis interactions in proliferant cells. Int. J. Biochem. 1990, 22:681-683.
24. Muruais G., Lalioti V., Sandoval I.V. The Cdk5 inhibitor roscovitine strongly inhibits glucose uptake in 3T3-L1 adipocytes without altering GLUT4 translocation from internal pools to the cell surface. J. Cell. Physiol. 2009, 220:238-244.
25. Nikiforov M.A., Riblett M., Tang W.H., Gratchouck V., Zhuang D., Fernandez Y., Verhaegen M., Varambally S., Chinnaiyan A.M., Jakubowiak A.J., Soengas M.S. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Proc. Natl. Acad. Sci. USA 2007, 104:19488-19493.
26. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000, 288:1053-1058.
27. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426:671-676.
28. Opferman J.T., Iwasaki H., Ong C.C., Suh H., Mizuno S., Akashi K., Korsmeyer S.J. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science 2005, 307:1101-1104.
29. Perez-Galan P., Roue G., Villamor N., Montserrat E., Campo E., Colomer D. The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status. Blood 2006, 107:257-264.
30. Ploner C., Kofler R., Villunger A. Noxa: at the tip of the balance between life and death. Oncogene 2008, 27(Suppl 1):S84-S92.
31. Rosales J.L., Lee K.Y. Extraneuronal roles of cyclin-dependent kinase 5. Bioessays 2006, 28:1023-1034.
32. Shibue T., Takeda K., Oda E., Tanaka H., Murasawa H., Takaoka A., Morishita Y., Akira S., Taniguchi T., Tanaka N. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev. 2003, 17:2233-2238.
33. Ubeda M., Kemp D.M., Habener J.F. Glucose-induced expression of the cyclin-dependent protein kinase 5 activator p35 involved in Alzheimer's disease regulates insulin gene transcription in pancreatic beta-cells. Endocrinology 2004, 145:3023-3031.
34. Vander Heiden M.G., Plas D.R., Rathmell J.C., Fox C.J., Harris M.H., Thompson C.B. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 2001, 21:5899-5912.
35. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
36. Villunger A., Michalak E.M., Coultas L., Mullauer F., Bock G., Ausserlechner M.J., Adams J.M., Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003, 302:1036-1038.
37. Wang Q., Mora-Jensen H., Weniger M.A., Perez-Galan P., Wolford C., Hai T., Ron D., Chen W., Trenkle W., Wiestner A., Ye Y. ERAD inhibitors integrate ER stress with an epigenetic mechanism to activate BH3-only protein NOXA in cancer cells. Proc. Natl. Acad. Sci. USA 2009, 106:2200-2205.
38. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
39. Warr M.R., Shore G.C. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr. Mol. Med. 2008, 8:138-147.
40. Willis S.N., Chen L., Dewson G., Wei A., Naik E., Fletcher J.I., Adams J.M., Huang D.C. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005, 19:1294-1305.
41. Zabos P., Kyner D., Mendelsohn N., Schreiber C., Waxman S., Christman J., Acs G. Catabolism of 2-deoxyglucose by phagocytic leukocytes in the presence of 12-O-tetradecanoyl phorbol-13-acetate. Proc. Natl. Acad. Sci. USA 1978, 75:5422-5426.
42. Zhao Y., Altman B.J., Coloff J.L., Herman C.E., Jacobs S.R., Wieman H.L., Wofford J.A., Dimascio L.N., Ilkayeva O., Kelekar A., et al. Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1. Mol. Cell. Biol. 2007, 27:4328-4339.